HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Supplement Firm Shut Down By Decree After Using Ingredient On FDA ‘Advisory List'

Products Recalled Month After Guilty Plea For Making COVID-19 Claims

Executive Summary

FDA's decree of permanent injunction with Fusion Health and Vitality filed same day the firm announced recall of its Core Essential Nutrients and Immune Boost Sublingual Vitamin D3 products found to contain hordenine HCl.

You may also be interested in...



FDA's Latest Hornedine Find Is On Texas Firm’s Supplement Labels During Website Inspection

Hornedine isn’t an “old” dietary ingredient exempt from pre-market notification with proof its safety because it wasn’t available in the US food supply before October 1994. "T

US Businessman Ignores Federal, State Regulators’ Warnings, Faces Criminal COVID-19 Fraud Charges

Federal prosecutors’ latest criminal case alleging fraudulent advertising and sales of vitamins and other nutrients available nonprescription in the US as remedies for infections from the novel coronavirus is against Johnny Stine, owner and operator of North Coast Biologics in Seattle.

US Recalls: GMP Problems Continue For Milbar

Recent updates to FDA’s recall records also suggest increasing demand for elderberry supplements for immune health benefits has led to the import of the fruit from suspect sources. A California firm determined more than 10,000 pounds of elderberry it imported from Croatia were contaminated with salmonella.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150733

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel